Prevalence of hyperlipidemia and its associated factors in university students in Colombia

Alba Aydeé Álvarez Ramírez, Jéssica López Peláez, Iván Mauricio Bermúdez, Jennifer Ysleni Gordon Botero, Alba Aydeé Álvarez Ramírez, Jéssica López Peláez, Iván Mauricio Bermúdez, Jennifer Ysleni Gordon Botero

Abstract

The present study aimed to determine the prevalence of hyperlipidemia and its associated factors in the students of the Faculty of Health of Universidad Santiago de Cali in 2017. A descriptive cross-sectional study was performed in a sample of 361 students, with an average age of 21 (16-40) years. A sociodemographic survey was conducted, and blood samples and lipid profiles were obtained. The participants were predominantly female (77%), single (92.5%), and young adults (62.3%) and with an average socioeconomic level (55.1%). The overall prevalence of hyperlipidemia was 33.8%, with the following risk values: triglyceride (TG), 12.8%; hypercholesterolemia, 16.1%; high density lipoprotein cholesterol (cHDL), 15.0%; and low-density lipoprotein cholesterol (cLDL), 42.2%. Using the theory of the logistic regression models and chi-square likelihood ratio tests, the factors that were significantly associated with the risk of hyperlipidemia were male sex and consumption of alcoholic beverages (P-value < 0.05). In the two-way ANOVA, it was observed that the interaction of these two factors for TG was significant (P-value < 0.05), being higher in men who consume intoxicating beverages (Tukey's test, P value <0.05). Regarding cHDL and cLDL, only sex presented a significant effect on their values (P-value < 0.05), while for total cholesterol, none was significant (P-value > 0.05). The results obtained indicate the importance of early detection of blood lipid levels in young people to prevent the early development of noncommunicable diseases.

Keywords: Chronic disease; Epidemiology; Health education; Health promotion; Hyperlipidemias; Lipids; Prevalence; Public health; Quality of life; Risk factors; Students; Well-being.

© 2020 The Authors.

References

    1. Galvis Perez Y., Barona Acevedo J., Cardona Arias .J.A. Prevalencia de dislipidemias en una Institución prestadora de servicios de salud de Medellín (Colombia), 2013. Revista CES Medicina. 2013;30(1):3–4. Available at:
    1. World Health Organization . 2017. World Conference on Noncommunicable Diseases. Geneva. Available at:
    1. World Health Organization Report on the global situation of noncommunicable diseases: meeting the nine global targets on noncommunicable diseases, a shared responsibility. Geneva. 2014. Available at:
    1. World Health Organization . 2017. Monitoring Progress on Noncommunicable Diseases. Geneva. Available at:
    1. Pan American Health Organization . Report of a WHO scientific group; Geneva: 2012. Noncommunicable Diseases: Country Profiles. Available at:
    1. Villarouca A.R., Nascimento L.S., Sousa T.R. Prevalência de componentes metabólicos em universitários. Rev. Latino-Am. Enferm. 2014;22(6):1041. Available at:
    1. Ministerio de Salud y Protección Social Guía de Práctica Clínica para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias en la población mayor de 18 años. Colombia. 2014. Available at:
    1. Ponte C.I., Isea P.J., Lorenzatti A.J., López J.P. Dislipidemia aterogénica en Latino América: prevalencia, causas y tratamiento. Rev. Venez. Endocrinol. Metab. 2017;15(2):106–129. Available at:
    1. Pramparo P., Boissonnet C., Schargrodsky H. Evaluation of cardiovascular risk in seven cities in Latin America: the main conclusions of the CARMELA study and substudies. Rev. Argent. Cardiol. 2011;79:377–382. Available at:
    1. Martínez R., Soliz P., Caixeta R., Ordunez P. Rev Panam Salud Pública; 2019. Años de vida perdidos por muerte prematura: una medida versátil y abarcadora para el monitoreo de la mortalidad por enfermedades no transmisibles. Available at:
    1. Institute for Health Metrics and Evaluation . EEUU; Seatle: 2018. Findings from the Global burden of Disease Study. Available at:
    1. World Health Organization . 2018. The Top Ten Causes of Death. Geneva. Available at:
    1. World Health Organization . 2003. The World Health Report: Global Health: Today´s Challenges. Geneva. Available at:
    1. Salomon J.A. World Health Organization; Geneva: 2013. New Disability Wights for the Global burden of Disease. Available at:
    1. Almonacid Urrego C., Camarillo Romerro M.D.S., Gil M.Z. 2016. Evaluación de factores de riesgo asociados a enfermedad cardiovascular en jóvenes universitarios de la localidad Santafé de Bogotá. Colombia. Available at:
    1. Polit D.F., Hungler B.P. 5 ed. McGraw-Hill Interamericana; México: 2002. Investigación científica en ciencias de la salud.
    1. Antal E., Tille Y. Simple random sampling with over-replacement. J. Stat. Plann. Inference. 2011;141(1):597–601.
    1. World Health Organization . 2016. International Ethical Guidelines for Health-Related Research Involving Humans. Geneva. Available at:
    1. Asociación Médica Mundial . 2013. Declaración de Helsinki. Ferney-Voltaire: Francia. Available at:
    1. Dankar F.K., Gergely M., Dankar S.K. Informed consent in biomedical research. Comput. Struct. Biotechnol. J. 2019;17:463–474.
    1. Ministerio de Salud Resolución 008430. 1993. Available at:
    1. World Health Organization . 2018. Maternal, Newborn, Child and Adolescent. Geneva. Available at:
    1. National Cholesterol Education Program, Adult Treatment Panel III Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. (Adult Treatment Panel III) JAMA Med. Assoc. 2001;285(19):2486–2497. Available at:
    1. Bax J., Vahanian A., Auricchio A. ESC/EAS guidelines for the management of dyslipidemias: the task force for the management of dyslipidemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS) Eur. Heart J. 2016;32(14):1769–1818. Available at:
    1. Nelder J.A., Wedderburn R.W.M. Generalized linear models. J. Royal Statis. Soc. Series A Gen. 1972;135(3):370–384.
    1. Dobson A.J., Barnett A.G. Chapman &Hall, CRC; Florida: 2018. An Introduction to Generalized Linear Models.
    1. Hosmer D.W., Lemeshow S. Jhon Wiley and Sons; New York: 2004. Applied Logistic Regression.
    1. Core T.R. R Foundation for Statistical Computing; Vienna, Austria: 2020. A Language and Environment for Statistical Computing. Available at:
    1. Gómez A.F., Tarqui M.C. Prevalencia de sobrepeso, obesidad y dislipidemia en trabajadores de salud del nivel primario. Rev Duazary Inter Cienc Salud. Perú. 2017;14(2):141–148.
    1. González C.E., Díaz B.Y., Mendizábal R.A. Prevalencia de obesidad y perfil lipídico alterado en jóvenes universitarios. Rev. Nutr. Hosp. 2014;29(2):315–321. Available at:
    1. Gotthelf S.J., Rivas P.C. Prevalence of dyslipidemia and its association with nutritional status in the population of the city of the Salta during 2014. Rev. Fed Arg Cardiol. 2016;45(4):184–189. Available at:
    1. Barja Y.S., Arnaiz G.P., Villarroel P.L. Dislipidemias en escolares chilenos: prevalencia y factores asociados. Rev. Nutr. Hosp. 2015;31:2079–2087.
    1. García G.I., Novelo A., López N.M. Prevalencia de dislipidemias en población urbana aparentemente sana de Yucatán. Rev Latinoam Patologia Clinica Medicinia Laboratorio. 2015;62(3):150–156. Available at:
    1. Freire R.W., Moura M.F., Soares A.C. Analise do perfil lipidico de uma população de estudantes universitarios. Rev. Latino-Am. Enferm. 2013;21(5):9. Available at:
    1. Casavalle P.L., Romano L., Pandolfo M. Prevalencia de dislipidemia y sus factores de riesgo en niños y adolescentes con sobrepeso y obesidad. Rev Esp española de nutrición Humana y dietética. 2014;18(3):137–144. Available at:
    1. Rodríguez D.L., Fernández B.J., Díaz S.M. Sobrepeso y dislipidemias en adolescentes. Rev. Cubana de Pediatría. 2014;86(4):433–444. Available at:
    1. Machado A.J., Machado D.M. Prevalencia de factores de riesgo cardiovascular en pacientes con dislipidemia afiliados al sistema de salud en Colombia. Rev. Peru. Med. Exp. Salud Pública. 2013;30(2):205–211.
    1. Martínez D.M., Soca M.P., Rodríguez H.R. 2018. Prevalencia de hipertrigliceridemia y factores de riesgo cardiovascular en estudiantes de la Universidad de Ciencias Médicas. Rev Medisur. Holguín: Cuba. Available at:
    1. Zhang Y., Vittinghoff E. Associations of blood pressure and cholesterol levels during Young adulthood with later cardiovascular events. J. Accounting. 2019;74(3):330–341.
    1. Shahwan M., Jairoun A., Farajallah A., Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes & Metabolic Syndrome. Clin. Res. Rev. 2019;13:2387–2392.
    1. Méndez G.J., Azaustre L.M. El consumo de alcohol en universitarios. Estudio de las relaciones entre las causas y los efectos negativos. Rev Complutense de educación. 2015;28(3):689–704.
    1. Betancourth Z.S., Tácan B.L., Córdoba P.E. Consumo de alcohol en estudiantes universitarios colombianos. Universidad y. Salud. 2017;19(1):37–50.
    1. Ja Kim C., Park J., Kang S. Health-promoting lifestyles and cardio-metabolic risk factors among international students in South Korea. Collegian. 2015;22:215–223. Korea del Sur.
    1. Nepal G., Tuladhar E. Dyslipidemia and associated cardiovascular risk factors among young Nepalese university students. Cureus. 2018;10(1):2089.
    1. Rosoff D.B., Charlet K., Jung J., Lee J., Muench C., Luo A. Association of high-intensity binge drinking with lipid and liver function enzyme levels. J. Am. Med. Assoc. 2019
    1. Yang L., Yang C. Lipophagy and alcohol-induced fatty liver. Front. Pharmacol. 2019;10:495.
    1. World Health Organization Non-communicable-diseases. Geneva. 2018. Available at:

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe